How Telmisartan and Nebivolol Work to Manage High Blood Pressure

Oct 17, 2026

TELMISTRUM NEBI 40/5 from Steris Healthcare is a fixed-dose combination tablet containing telmisartan 40 mg and nebivolol 5 mg. It is prescribed to help adults with high blood pressure (hypertension) when one medicine alone is not enough, or when a doctor wants the benefits of both an angiotensin receptor blocker (ARB) and a beta-blocker in one tablet.

In plain terms:

  • Telmisartan relaxes your blood vessels by blocking the hormone angiotensin II, which normally tightens them.
  • Nebivolol slows and relaxes the heart, and also widens blood vessels through a nitric oxide pathway.

Together, they lower blood pressure by two different routes, and the heart does less work.

Why Is Telmisartan Important in Treating High Blood Pressure?

High blood pressure often has no symptoms, yet over the years it damages the heart, brain, kidneys, eyes, and blood vessels. It is a leading risk factor for stroke, heart attack, heart failure, and kidney disease, and it is very common in India. Many people need more than one drug to reach their target, because the body has several overlapping systems that raise blood pressure.

Telmisartan matters in this picture for several reasons:

  • Long action. Telmisartan has one of the longest half-lives among ARBs (around 24 hours), which supports smooth 24-hour control with once-daily dosing, including in the early morning when risk is high.
  • Protection beyond blood pressure. In the large ONTARGET trial, telmisartan was found to be comparable to ramipril in reducing cardiovascular events in high-risk patients, and it was better tolerated, with less cough and angioedema.
  • Kidney-friendly profile. ARBs are widely used in people with diabetes and early kidney disease, because they reduce protein leakage in the urine.
  • Partial PPAR-gamma activity. Laboratory data suggest telmisartan may have mild effects on glucose and fat metabolism. The clinical importance of this is not established, so it should not be treated as a diabetes treatment.

Nebivolol adds value because it is a highly beta-1 selective beta-blocker with an extra vasodilating action. This makes it a useful partner when a patient also has a fast heart rate, angina, a previous heart attack, or certain heart failure conditions.

A single combined tablet also helps people stick to treatment, which is one of the biggest challenges in hypertension care.

Key Benefits 

What Are the Benefits of Telmisartan and Nebivolol Together?

1. Stronger blood pressure reduction. Two drugs working through different pathways usually lower blood pressure more than either one alone at a starting dose.

2. Heart rate control. Nebivolol slows the resting heart rate, which helps people whose hypertension comes with palpitations or a fast pulse.

3. Lower workload on the heart. Both drugs reduce the strain on the heart, which can matter in people with angina or after a heart attack.

4. Smoother control through the day. Both drugs are suitable for once-daily use.

5. Vasodilating beta-blocker. Unlike older beta-blockers, nebivolol increases nitric oxide, which helps the arteries relax. It tends to cause less fatigue, cold extremities, and sexual side effects than older beta-blockers like atenolol, although it can still cause them.

6. Fewer tablets. A single tablet is easier to remember than two, which supports adherence.

7. Good tolerability for many people. Telmisartan has a lower rate of cough than ACE inhibitors, and nebivolol has a relatively favorable metabolic profile among beta-blockers.

8. Flexible and cost-effective. Both drugs are widely available as generics in India.

Mechanism of Action: 

Composition: Each tablet of TELMISTRUM NEBI 40/5 contains telmisartan 40 mg and nebivolol (usually as nebivolol hydrochloride) 5 mg. Check your pack for the exact label claim and excipients.

Telmisartan (angiotensin II receptor blocker)

Angiotensin II is a powerful hormone that narrows blood vessels, makes the body hold sodium and water, and stimulates aldosterone release. Telmisartan selectively blocks the AT1 receptor, so these effects are reduced. The result is wider blood vessels, less fluid retention, and lower blood pressure. It does not affect bradykinin the way ACE inhibitors do, which is why dry cough is much less common.

Nebivolol (beta-1 selective blocker with nitric oxide-mediated vasodilation)

Nebivolol blocks beta-1 receptors in the heart, which lowers heart rate, the force of contraction, and the release of renin from the kidney. In addition, it stimulates the release of nitric oxide from the lining of blood vessels (partly through beta-3 receptor activity), which relaxes the arteries and lowers resistance. Nebivolol is processed by the liver enzyme CYP2D6.

Why the pairing makes sense

The combination attacks the renin-angiotensin system (telmisartan) and the sympathetic nervous system (nebivolol) at once. Beta-blockers tend to raise renin, and ARBs counter that, so the two complement each other.

Indications, Efficacy and Clinical Evidence

Indications (as prescribed by doctors)

  • Essential hypertension in adults, when a combination is appropriate
  • Hypertension in patients who also have a fast heart rate, angina, or a history of heart attack, as judged by the doctor
  • Patients already stable on telmisartan and nebivolol as separate tablets, who can be switched to the combination

It is not meant for starting treatment in every patient, and it is not for emergency blood pressure crises.

What the evidence shows

Accurate reporting matters for E-E-A-T, so here is what is known:

  • Telmisartan: Clinical trials show telmisartan lowers blood pressure effectively at 40 to 80 mg once daily, with an effect that lasts through the full dosing interval. The ONTARGET trial (about 25,000 high-risk patients) found telmisartan non-inferior to ramipril for cardiovascular outcomes, and the combination of the two did not help and caused more adverse events. In the TRANSCEND trial, in patients unable to tolerate ACE inhibitors, telmisartan did not significantly reduce the primary outcome compared with placebo, but showed a benefit in a secondary outcome.
  • Nebivolol: Studies show it lowers blood pressure similarly to other major drug classes, with good tolerability. In the SENIORS trial of older patients with heart failure, nebivolol reduced the combined risk of death or cardiovascular hospitalization.
  • The fixed-dose combination: Studies of telmisartan combined with a beta-blocker, or of nebivolol combined with an ARB, have generally shown additive blood pressure lowering. However, large long-term outcome trials of this specific fixed-dose pairing are limited. Most of the evidence comes from the individual drugs and smaller combination studies.
  • Guideline context: Many international guidelines recommend ACE inhibitors or ARBs, calcium channel blockers, and diuretics as first-line options for uncomplicated hypertension, with beta-blockers reserved for patients with specific conditions such as heart failure, angina, previous heart attack, or certain arrhythmias. An ARB plus beta-blocker combination is therefore best suited to patients who have such a need. Your doctor will decide whether it fits your case.

No clinical study specific to this brand’s formulation is cited here. For bioequivalence data or batch documentation, ask Steris Healthcare directly.

Side Effects 

Many people tolerate the combination well. Common effects include:

  • Dizziness or light-headedness, especially when standing up quickly
  • Headache
  • Tiredness or weakness
  • Slow heartbeat (bradycardia)
  • Back pain, muscle pain, or joint pain
  • Diarrhea, nausea, or stomach upset
  • Cold hands and feet, or tingling (paresthesia)
  • Trouble sleeping or unusual dreams
  • Mild upper respiratory symptoms, such as a stuffy nose or sore throat

Dosage Guidelines 

The right dose depends on your blood pressure, other conditions, kidney and liver function, age, and other medicines. The prescription and label take priority. As a general guide:

  • The usual adult dose is one tablet once daily, at about the same time each day.
  • It can be taken with or without food. Keep the routine consistent.
  • Swallow the tablet whole with water.
  • Doctors usually check blood pressure and heart rate after a few weeks, and the regimen may be adjusted by changing to a different strength or to separate tablets.
  • Telmisartan reaches most of its blood-pressure-lowering effect within about 4 weeks, so do not judge it too early.
  • If you miss a dose, take it when you remember on the same day. If it is almost time for the next dose, skip the missed one. Do not take two tablets together.
  • Do not stop suddenly. Abruptly stopping a beta-blocker can cause a rebound rise in heart rate and blood pressure, chest pain, or, in rare cases, a heart attack. Your doctor will taper the dose if needed.
  • People with kidney or liver problems, and older adults, may need lower doses or closer monitoring.

This combination is not recommended for children, unless a specialist advises otherwise.

Precautions & Warnings: 

  • Pregnancy: Do not use. Telmisartan and other ARBs can harm or even cause death of a developing baby, particularly in the second and third trimesters. Tell your doctor immediately if you become pregnant or are planning pregnancy.
  • Breastfeeding: Not recommended unless your doctor advises it.
  • Heart conditions: Nebivolol is avoided in severe slow heart rate, sick sinus syndrome, second- or third-degree heart block, cardiogenic shock, and decompensated heart failure.
  • Low blood pressure: Avoid if your systolic blood pressure is very low.
  • Asthma and COPD: Use with great caution. Nebivolol is beta-1 selective, but bronchospasm can still occur.
  • Diabetes: Monitor blood sugar, because beta-blockers can mask the signs of low blood sugar.
  • Liver disease: Nebivolol is avoided in severe liver impairment. Telmisartan is avoided in biliary obstruction and used cautiously in liver disease.
  • Kidney disease and renal artery stenosis: Telmisartan can worsen kidney function in bilateral renal artery stenosis or in severe dehydration. Kidney function and potassium should be checked before starting and periodically.
  • Potassium: Avoid potassium supplements and salt substitutes containing potassium unless your doctor advises it, as they can cause high potassium.
  • Surgery and anesthesia: Tell your doctor or anesthetist before any procedure.
  • Dehydration: Vomiting, diarrhea, or heavy sweating can lower blood pressure too much. Ask your doctor whether to pause the medicine.
  • Lifestyle: Medicines work best with less salt, regular exercise, healthy weight, limited alcohol, and no tobacco.
  • Driving: Dizziness can occur, particularly at the start. Be careful until you know how you react.
  • Monitoring: Home blood pressure readings, and checks of kidney function, potassium, and heart rate help guide safe use.
  • Storage: Keep in a cool, dry place away from light and moisture, and out of the reach of children. Do not use after the expiry date.

Why Buy from Steris Healthcare?

Steris Healthcare is an Indian pharmaceutical company that supplies medicines and healthcare products to hospitals, clinics, pharmacies, and distributors across India. For buyers looking for TELMISTRUM NEBI 40/5 or any telmisartan 40 mg and nebivolol 5 mg tablet, verify these points before ordering:

  • Valid drug license and manufacturer details on the pack
  • Batch number, manufacturing date, and expiry date
  • Clear composition labeling with the strength of each ingredient
  • Proper storage and handling in transport
  • Prescription verification, since this is a Schedule H drug

Frequently Asked Questions

1. What is TELMISTRUM NEBI 40/5 used for?
It is used for high blood pressure in adults. It contains telmisartan 40 mg and nebivolol 5 mg, which lower blood pressure by different mechanisms.

2. What are the uses of telmisartan 40 mg?
It treats hypertension and is also used to lower the risk of heart attack and stroke in certain high-risk patients, as decided by a doctor.

3. What is nebivolol 5 mg tablet used for?
It is used for high blood pressure, and sometimes for heart failure in older adults, angina, or heart rate control.

4. How do telmisartan and nebivolol work together?
Telmisartan blocks angiotensin II to relax blood vessels, and nebivolol slows the heart and widens arteries through nitric oxide. Together they lower blood pressure more effectively.

5. Is telmisartan the same as telmisartan and amlodipine?
No. Telmisartan + amlodipine is a different combination with a calcium channel blocker. TELMISTRUM NEBI 40/5 contains nebivolol instead of amlodipine.

6. When should I take this tablet?
Take one tablet once daily, at the same time each day, with or without food, as prescribed.

7. How long does it take to work?
Some effect appears within hours, but full blood pressure lowering from telmisartan takes about 4 weeks.

8. What are the common side effects?
Dizziness, headache, tiredness, slow heartbeat, back or muscle pain, cold hands and feet, and stomach upset.

9. What are the serious side effects?
Angioedema (swelling of the face or throat), very low blood pressure, heart block, high potassium, kidney problems, worsening heart failure, and wheezing. Seek medical help immediately.

10. Can I stop the tablet suddenly?
No. Stopping a beta-blocker suddenly can cause a rebound rise in heart rate and blood pressure, chest pain, or other heart problems. Your doctor will taper the dose.

Conclusion

TELMISTRUM NEBI 40/5 by Steris Healthcare combines telmisartan 40 mg and nebivolol 5 mg in one tablet for adults with hypertension who need more than a single drug, or who benefit from heart rate control as well. Telmisartan relaxes blood vessels by blocking angiotensin II, and nebivolol slows the heart while widening arteries through nitric oxide. Together they offer smooth, once-daily blood pressure control and added convenience.

The medicine must be used with care. It is not suitable in pregnancy, severe slow heart rate, heart block, or decompensated heart failure, and it should never be stopped suddenly. Regular checks of blood pressure, heart rate, kidney function, and potassium keep treatment safe. Because beta-blockers are not first-line for every patient, the combination works best when it is chosen by a doctor for a clear reason.

For Further Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +91 8824175417, +91 9982524671

Buy Now

SHARE WITH